Related Topics | CHOP Research Institute
Request an Edit
Skip to main content

CORONAVIRUS UPDATES

Find information and resources about the Research Institute's COVID-19 response

HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP

Utility Nav

  • CHOP.EDU
  • Careers
  • Give
  • Healthcare Professionals
  • International
CHOP RI LogoChildren's Hospital of Philadelphia
Menu

Main navigation

  • Find People
  • Our Research
  • Clinical Trials
  • About
  • Innovation
  • Faculty & Staff Resources
  • Make a Gift
 

Results for Sickle Cell Anemia

1 - 10 of 21

Stella T. Chou, MD
Stella T. Chou, MD

Dr. Chou focuses on regenerative blood cellular therapy, the mechanisms of normal human hematopoietic development, and the pathophysiology of pediatric hematologic diseases.

E-mail:
chous [at] chop.edu
Helge Hartung, MD
Helge Hartung

Dr. Hartung is the interim director of CHOP's Sickle Cell Center and the director of innovation of the CuRED Frontier Program. His clinical focus is on bone marrow failure syndromes and sickle cell disease and his research focus is on entrepreneurial science and medical device development.

E-mail:
hartungh1 [at] chop.edu
Stefano Rivella, PhD
Stefano Rivella

Dr. Rivella is an expert in the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies. He also investigates additional disorders such as anemia of inflammation and hemochromatosis.

E-mail:
rivellas [at] chop.edu
Timothy S. Olson, MD, PhD
Timothy S. Olson Headshot

Dr. Olson aims to improve diagnostics and treatment of bone marrow failure (BMF) syndromes, and to improve clinical hematopoietic stem cell transplantation (HSCT) outcomes. He conducts clinical trials of HSCT for non-malignant hematologic diseases. His laboratory explores both basic and translational research focused on genomics of BMF and the impact of BMF on hematopoietic niche function during HSCT.

E-mail:
olsont [at] chop.edu
Amaliris Gonzalez, PhD
Amaliris Gonzalez

Dr. Guerra is researching innovating therapies to treat β-thalassemia and sickle cell anemia and use lentiviruses as a tool. Her work aims to discover new biological targets that can be used to treat β-thalassemia and other forms of anemia.

E-mail:
gonzaleza2 [at] chop.edu
Carlo Castruccio Castracani, PhD
Carlo Castruccio Castracani

Dr. Castracani’s research work is focused on the most common form of X-linked sideroblastic anemia which results from mutations in the ALAS2 gene and inhibits normal heme biosynthesis.

E-mail:
castruccic [at] chop.edu

Multi-tasking Vector to the Rescue of Red Blood Disorders

Published on
Jun 2, 2021
in Cornerstone Blog
Multi-tasking Vector to the Rescue of Red Blood Disorders
Stefano Rivella, PhD, is developing a new gene therapy — a multitasking vector — for treatment of red blood disorders.

Meet the 2021 Recipients of the Distinguished Research Trainee Awards

Published on
May 21, 2021
in Cornerstone Blog
Meet the 2021 Distinguished Research Trainee Award Winners
The 2021 Distinguished Research Trainee Award recipients include trainees from a variety of levels and disciplines.

Celebrating ‘Coordinator Intelligence:’ The Eighth Annual CRC RE@CH Awards

Published on
May 19, 2021
in Cornerstone Blog
The Eighth Annual CRC RE@CH Awards
The CRC RE@CH Awards celebrated the professionals whose exceptional work contributes to important research at CHOP.

Snapshot Science: Will a New Vector Offer Safer Gene Therapy for Red Blood Disorders?

Published on
Feb 1, 2021
in Cornerstone Blog
Snapshot Science: Will a New Vector Offer Safer Gene Therapy for Red Blood Disorders?
CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.
1 - 10 of 21

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ››
  • Last page Last »
Back to previous page

In this section

Filter By

  • Principal Investigator / Faculty (4)
  • Researcher / Lab Personnel (2)

Organizations

  • Division of Hematology (7)
  • Department of Pediatrics (4)
  • Rivella Laboratory (4)
  • Comprehensive Center for the Cure of Sickle Cell Disease and Other Red Blood Cell Disorders (2)
  • Center for Injury Research and Prevention (1)
  • Center for Violence Prevention (1)
  • Department of Pathology and Laboratory Medicine (1)
  • Division of Allergy and Immunology (1)
  • Division of Neonatology (1)
  • Raymond G. Perelman Center for Cellular and Molecular Therapeutics (1)

In this section

Filter By

  • Principal Investigator / Faculty (4)
  • Researcher / Lab Personnel (2)

Organizations

  • Division of Hematology (7)
  • Department of Pediatrics (4)
  • Rivella Laboratory (4)
  • Comprehensive Center for the Cure of Sickle Cell Disease and Other Red Blood Cell Disorders (2)
  • Center for Injury Research and Prevention (1)
  • Center for Violence Prevention (1)
  • Department of Pathology and Laboratory Medicine (1)
  • Division of Allergy and Immunology (1)
  • Division of Neonatology (1)
  • Raymond G. Perelman Center for Cellular and Molecular Therapeutics (1)
CHOP Research Institute

3401 Civic Center Blvd.
Philadelphia, PA 19104

© 2022 Children's Hospital of Philadelphia. All Rights Reserved.

Privacy Policy | Terms of Use | HIPAA Notice of Privacy Practices | Ethics & Compliance

CHOP Directory

  • Main Hospital 1-800-879-2467
  • Foundation 267-426-6500
  • Research 215-590-3800
  • Referring Physicians 1-800-879-2467

Research Institute

  • About CHOP Research Institute
  • Our Research
  • Organizational Chart
  • News & Media
  • Events
  • Staff Resources

Find a...

  • Researcher
  • Clinical Trials
  • Research Labs
  • Core Facility
  • Academic Department

Our Organization

  • About CHOP
  • Patient Care
  • Giving
  • For Healthcare Professionals
  • Careers
  • International